The test is designed to help clinicians either rule in or rule out amyloid pathology in patients showing signs of cognitive decline
Researchers reported that patients treated with the wearable system were discharged around five days earlier than those receiving standard hospital-based care
The company also confirmed that ABS-1230 has been accepted into the U.S. Food and Drug Administration’s Rare Disease Evidence Principles (RDEP) process
High-resolution analytical platforms from Agilent Technologies will be made available through C-CAMP’s shared infrastructure model under expanded collaboration
This marks the second consecutive year that Juneja has made a personal contribution towards supporting the armed forces
Shashwat Goenka takes over as Vice President of industry body
IIT Kanpur team has developed computational framework to map how cell signals influence gene activity across tissues
Healthcare leaders, policymakers, hospitals, and patient advocates discuss AI-driven healthcare, digital transformation, quality of life in cancer care
The once-daily oral therapy is the first and only tyrosine kinase 2 (TYK2) inhibitor approved in the European Union for this indication, marking a significant expansion of its immunology portfolio
Mumbai event on June 24–25 will spotlight real-world impact of pharmacovigilance beyond AI adoption
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
